Background. Staphylococcus aureus superantigens are associated with the pathogenesis of toxic shock syndrome, but their involvement in septic shock is unknown.
of septic shock increased by an average of 8.7% per year in the United States [6] , whereas the incidence of STSS remained low. Between 1998 and 2001, only 40-50 cases of STSS were diagnosed per year in France (population, 60 million) [7] .
S. aureus virulence determinants include adhesions and toxins [8] . Some S. aureus toxins, such as toxic shock syndrome toxin-1 (TSST-1) and enterotoxins, have superantigenic properties. Superantigens bypass normal antigen presentation and have strong T cell mitogenic activity by binding to a specific variable region of the T cell antigen receptor-b-chain [9] . This leads to a massive release of proinflammatory T-helper cell type 1 (Th1) cytokines, such as TNF-a, IL-6, and IFN-g. This disproportionate proinflammatory activity is responsible for the physiopathology of STSS [4, 5] . Th1 cytokines are also involved in septic shock, but the systemic host's response is mainly macrophage dependent [10] . Systemic reactions to superantigens may also contribute to the severity of S. aureus sepsis [11] . Genes encoding superantigens are not only present in S. aureus strains associated with STSS, but also in ∼70% of nasal carriage strains [12] [13] [14] . The specific prevalence and distribution of different S. aureus superantigens in blood culture isolates obtained from patients with septic shock is unknown.
We conducted a case-control study to determine the distribution of superantigen genes among S. aureus blood culture isolates obtained from patients with sepsis, with or without septic shock, compared with the distribution among isolates obtained from patients with nonbacteremic suppurative diseases and patients with colonization.
PATIENTS AND METHODS

Definition.
Systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic shock were defined according to the criteria of the American College of Chest Physicians and the Society of Critical Care Medicine Conference [15] . SIRS was defined by the presence of у2 of the following manifestations: body temperature, 138ЊC or !36ЊC; heart rate, , or 110% of immature neutrophils). Sepsis was defined by the presence of SIRS associated with infection, and severe sepsis was defined as sepsis associated with transient hypotension, organ dysfunction, or hypoperfusion. Septic shock was defined as sepsis-induced hypotension despite adequate fluid resuscitation, with hypoperfusion or organ dysfunction. STSS was defined as described elsewhere [4, 5] . Infections were considered to be hospital-acquired if they occurred 48 h after admission in a patient with no evidence of infection on admission. Community-acquired infections were considered to be health care-related if the patient had a recent history of hospitalization or another risk factor for infection by a methicillin-resistant strain of S. aureus (MRSA) of hospital origin [16] . All other infections were considered to have been community-acquired.
Selection of case patients and control patients. We enrolled adults with bacteremia diagnosed at Edouard Herriot Hospital (Lyon, France), a 1100-bed, inner-city university hospital offering medical and surgical acute care services. Patients were eligible if they had an episode of SIRS and у1 S. aureuspositive blood culture result. Patients were not eligible if they also had hemorrhagic shock, initial cardiogenic shock, or у1 blood culture yielding a species other than S. aureus. A case patient was defined as a patient with S. aureus sepsis with septic shock, and a control patient was defined as a patient with S. aureus sepsis without shock.
Data collection.
All patients were recruited in 2003. Thirty-one patients were recruited from intensive care units, and 49 patients were recruited from other units. Data collection was performed after recruitment. To obtain an adequate ratio of 1 case patient to 3 or 4 control patients, we limited inclusion of patients from medical and surgical units to a period of 7 months.
Clinical data. The following clinical data were recorded on the day that a positive blood culture result was obtained: age, sex, comorbidity (hematologic disorders, current malignancy, diabetes mellitus, HIV infection, and cirrhosis), receipt of chronic steroid therapy (11 month), receipt of other current immunosuppressive therapies, length of hospital stay, site of infection, central temperature, pulse, blood pressure, and respiratory rate. Microbiological data. S. aureus was identified by standard microbiological methods, including Gram staining, use of the Phoenix Automated Microbiology System (BD Biosciences), and production of coagulase (bioMérieux), thermostable DNase, catalase, and clumping factor (Pastorex Staph-plus; BioRad). Genomic DNA was extracted from staphylococci grown in brain-heart infusion broth and was used as a template for amplification with primers from Eurogentec (Seraing) in a TechGene thermal cycler (Edvodek). The quality of the DNA extracts and the absence of PCR inhibitors were confirmed by gyrA amplification. The accessory gene regulator (agr) allele group (1-4), 10 staphylococcal enterotoxin genes (sea, seb, sec, sed, see, seh, sek, sel, sem, and seo), the tst gene (encoding TSST-1), and the mecA gene (encoding methicillin resistance) were detected by multiplex PCR, as has been described elsewhere [12, 17] . Because the sed and sej genes are located on the same mobile genetic element, sed-positive isolates were also considered to have been sej positive. Because seg, sei, sem, sen, and seo genes belong to the enterotoxin gene cluster (egc), isolates that were positive for sem and seo genes were also considered to be positive for the egc gene. All PCR products were analyzed by electrophoresis through ethidium bromide-stained 1% agarose gel.
Comparative analyses. Data for patients with SIRS and S. aureus bacteremia were compared with data from the National Reference Center for Staphylococci (Lyon, France) concerning 126 S. aureus isolates collected from Lyon hospitals between January 2003 and February 2004: 101 isolates were obtained from patients with suppurative diseases (35 isolates were obtained from patients with collected abscess, 28 were obtained from patients with impetigo and cutaneous lesions with signs of impetiginization or infection, 12 were obtained from patients with bone or joint infection, 7 were obtained from patients with pneumonia, 7 were obtained from patients with finger pulp infection, 4 were obtained from patients with furuncles, and 8 were obtained from patients with other diseases, such as meningitis, inflammatory adenopathy, and mastoiditis); 25 isolates were obtained from patients with colonization. To minimize the overrepresentation of certain genes caused by clonal spread (e.g., an epidemic caused by a MRSA clone), only 1 toxin gene profile from each clinical environment was used for comparison with other environments.
Data analysis. Statistical analyses were performed with SPSS software (SPSS) . Differences between groups were tested 
RESULTS
Demographic and clinical characteristics. Eighty patients were enrolled in the study. They comprised 19 case patients with septic shock and 61 control patients with sepsis without shock. Eleven patients (including 5 patients with polymicrobial blood culture results, 2 with cardiogenic shock, 1 with hemorrhagic shock, and 3 who were not hospitalized at the Edouard Herriot hospital) were subsequently excluded. The demographic and clinical characteristics of the case patients and control patients are shown in Relation to shock. The prevalence of superantigen genes did not differ between isolates obtained from case patients and (table 2) . However, septic shock tended to be associated with a higher prevalence of the sea gene (47.4% in case patients and 34.4% in control patients; OR, 1.7; 95% CI, 0.6-4.87;
) and with a lower prevalence of the egc gene P p .31 (26.3% among case patients, and 50.8% among control patients; OR, 0.34; 95% CI, 0.11-1.08;
). P p .055 Comparison with National Reference Center isolates. When the national reference center isolates were included in the analysis, the prevalence of the sea gene increased significantly with the severity of infection (figure 1), from 8% among isolates obtained from patients with colonization to 16.8% among isolates obtained from patients with suppurative diseases, 34.4% among isolates obtained from patients with sepsis without shock, and 47.4% among isolates obtained from patients with sepsis and shock ( ). Conversely, the prev-P ! .001 alence of the egc gene decreased significantly with the severity of infection, from 68% among isolates obtained from colonization sites to 53.4% among isolates obtained from patients with suppurative diseases, 50.8% among isolates obtained from patients with sepsis without shock, and 26.3% among isolates obtained from patients with sepsis and shock ( ). When P p .009 isolates obtained from colonized patients, patients with suppurative diseases, and patients with sepsis were combined for analysis, the prevalence of the sea gene was significantly higher ( ) and the prevalence of the egc gene was significantly P ! .02 lower (P ! .03) in patients with septic shock (table 3) .
To minimize the bias due to clonal spread (e.g., an epidemic caused by a MRSA clone), the profile in question was only counted once if 11 identical 10-gene profile was detected in a given clinical category. Thus, 127 of 206 isolates were excluded, and the analysis was performed on the 79 remaining isolates (table 4). Of these, 11 isolates (instead of 19 isolates) were obtained from patients with septic shock. For the other situations, the number of studied isolates decreased to 68 isolates, instead of 187 isolates. The prevalence of the sea gene was still higher and the prevalence of the egc gene still lower in patients with septic shock, but not significantly ( and , P p .46 P p .19 respectively).
DISCUSSION
The involvement of gram-positive bacteria in life-threatening sepsis has been increasing steadily for several decades, but the implication of different virulence factors remains incompletely understood [6] . S. aureus is a frequently involved bacterium and does not contain lipopolysaccharide (LPS), a potent mediator of sepsis due to gram-negative bacteria, but it can produce a range of proinflammatory molecules: cell-wall components, such as peptidoglycans and lipoteichoid acid, and exotoxins, such as superantigens. Data obtained from animal models have demonstrated that superantigenic S. aureus toxins and LPS very efficiently synergyze in the induction of a lethal shock. Thus, a 2-hit model of septic shock has been suggested by Bannan et al. [18] . First, a bacterial cell-wall component (peptidoglycans, lipoteichoid acid, or LPS from a coinfection) stimulates the innate immune response through activation of monocytes and macrophages, and, second, a superantigen or other T cell stimulant amplifies an inflammatory response through the adaptive immune system [18, 19] . This mechanism has not been demonstrated in human cases of septic shock, and the capacity of S. aureus isolates involved in these cases to produce different superantigenic toxins has not been analyzed.
In the present study, we determined the presence of genetic loci for 10 different superantigens in S. aureus isolated from bloodstream infections in 19 case patients with septic shock and 61 control patients without shock. Overall, 86.2% of all isolates contained at least 1 superantigen gene, a prevalence similar to that reported by Becker et al. [13, 20] in previous surveys (73% and 80% in 219 and 429 blood culture isolates, respectively). The overall prevalence of superantigen genes did not differ between isolates from patients with septic shock (78.9%) and septic patients without shock (85.2%). On analysis of individual superantigen gene loci and after including isolates from other clinical conditions in the analysis, we found that the presence of the sea gene was significantly correlated with severity of infection, whereas the presence of the egc gene was negatively correlated.
Peacock et al. [14] found that the sea gene was significantly more common in invasive isolates, but not after omitting the epidemic MRSA-16 clone, which is highly prevalent in the United Kingdom. In our experience, the association of the genetic profile with the 10 superantigen genes, the agr locus, and the mecA gene adequately represents the genetic background [21] . To minimize the influence of clonal spread, we subsequently eliminated all but one of each isolate with an identical genetic profile, which limited the number of MRSA isolates. The association of the sea gene with clinical severity persisted, but the prevalence of the sea gene was no more significantly higher in patients with septic shock (table 4) . A linkage disequilibrium between the sea gene and у1 other virulence determinant located elsewhere in the genome of clonal staphylococcal strains (Peacock's "hitchhiker effect") is possible, but a specific role of SEA protein in septic shock cannot be excluded as SEB that may promote abscess and soft-tissue infection in an injection drug user [22] . First, SEA may synergize with bacterial cell-wall components and trigger the host inflammation response. Second, a simultaneous expression of invasive exoproteins (that favor bacterial spread to adjacent tissues) could coexist with production of SEA, because SEA lacks the cross-repressive activity of other superantigens, such as TSST-1 and SEB [23, 24] . S. aureus strains that produce SEA might have powerful advantages for inducing shock, and the spread of sea-positive MRSA clones could also contribute to the 75% increase in the attack rate of septic shock observed among patients in French intensive care units from 1993 and 2003 [25] . Eight cases of septic shock in our study were infected by MRSA strains, of which 7 carried the sea gene. Earlier studies of the presence of the sea gene in S. aureus isolates obtained from blood or other specimens from patients with invasive disease did not separate cases of septic shock for analysis [13, 14, 20] . For example, Becker et al. [13] reported the presence of the sea gene in only 17.4% of S. aureus blood isolates, without analyzing shock as a category. The power of our study was optimized by the inclusion of 3 controls for each case of septic shock, whereas 9 of 10 patients with S. aureus bacteremia usually do not develop septic shock (T. Ferry, unpublished data).
In contrast to the sea gene, the egc locus, which is located in the S. aureus pathogenicity island 3, was negatively correlated with the severity of infection. This locus includes an operon containing 5 newly described superantigen genes, seg, sei, sem, sen, and seo [12, 26] . This unique superantigen nursery is expressed in the early exponential-growth phase, whereas most other exoproteins, including enterotoxins, are expressed postexponentially [12, 27] . The egc locus is highly prevalent in clinical strains of S. aureus, especially in carriage strains (67% according to Peacock et al. [14] ) and may reduce pathogenicity in several ways. The mobile genetic element that carries the egc locus might, on insertion, inactivate a crucial sequence or cause the loss of another mobile genetic element carrying virulence genes [28] . Alternatively, the egc toxins may themselves have a protective effect through their intrinsic properties and the kinetic level of their production. Each member of the egc locus stimulates human T lymphocytes in vitro, and each has a distinct pattern of Vb activation. Together, they can activate most human lymphocytes [12] , but they seem to be produced in lesser quantities and to have a lower immunogenic response than do other enterotoxins. A minority of S. aureus strains carrying seg and sei genes produce detectable SEG and SEI proteins in vitro [29] . SEM, SEN, and SEO have no emetic activity in animal models [29, 30] , and egc products rarely elicit strong antibody responses [12, 27] . A recent study also showed that functional T-helper cell differentiation could be influenced by the superantigen concentration. In an in vitro purified human CD4 + -T cell model, high concentrations of TSST-1 generated a Th1 profile and lower concentrations generated a T helper-2 (Th2) profile [31] . Therefore, in the course of egcpositive S. aureus infection, early low-level egc toxin production might induce an early and mild Th2 response that could counteract the Th1 response and thereby limit the excessive release of Th1 cytokines that leads to shock.
In conclusion, this study confirms that most S. aureus strains that cause sepsis, with or without shock, harbor у1 gene encoding a superantigen. We also show that the presence of the sea gene was significantly correlated with the severity of infection. During sea-positive S. aureus sepsis, the SEA protein could trigger overexpression of inflammatory mediators that favor the onset of shock. Conversely, the presence of the egc locus was negatively correlated with the severity of infection. The integration of the S. aureus pathogenicity island 3 or early lowlevel production of egc-encoded toxins may exert a moderating effect, perhaps through stimulation of a Th2 response. However, molecular analysis of strains does not ascertain the in vivo production of superantigens. A study of the T cell Vb repertoire of patients with septic shock would confirm this hypothesis. If so, therapies targeting the production of superantigens, particularly SEA, might help to limit the severity of S. aureus septic shock. In this respect, it is noteworthy that the new antibacterial agent linezolid (active even against MRSA strains) reduces in a concentration-dependent manner SEA secretion in vitro [32] .
